Investigational Drug Information for Centhaquine
What is the drug development status for Centhaquine?
Centhaquine is an investigational drug.
There have been 5 clinical trials for Centhaquine.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 13th 2021.
The most common disease conditions in clinical trials are Hypovolemia, Shock, and Hemorrhage. The leading clinical trial sponsors are Pharmazz, Inc. and [disabled in preview].
There is one US patent protecting this investigational drug.
Summary for Centhaquine
| US Patents | 1 |
| International Patents | 0 |
| US Patent Applications | 13 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2021-08-13) |
| Vendors | 48 |
Recent Clinical Trials for Centhaquine
| Title | Sponsor | Phase |
|---|---|---|
| Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS | Pharmazz, Inc. | Phase 2 |
| A Phase-III Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent | Pharmazz, Inc. | Phase 3 |
| A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients | Pharmazz, Inc. | PHASE4 |
Clinical Trial Summary for Centhaquine
Top disease conditions for Centhaquine
Top clinical trial sponsors for Centhaquine
US Patents for Centhaquine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Centhaquine | ⤷ Start Trial | Therapeutic treatments using centhaquin | Midwestern University Downers Grove , Midwestern University Glendale | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
